Top compounds associated with response to WDR37


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan FIMM pan-cancer AAC 0.44 0.0006
mRNA etoposide CTRPv2 pan-cancer AAC 0.1 0.0006
mRNA Zebularine CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 0.0009
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.11 0.0009
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA phenformin GDSC1000 pan-cancer AAC 0.11 0.001
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
Download CSV